LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 73 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2016. The put-call ratio across all filers is 1.19 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $3,698,000 | +28.5% | 210,978 | +74.4% | 0.22% | +99.1% |
Q3 2016 | $2,878,000 | -12.7% | 120,964 | -41.3% | 0.11% | -37.2% |
Q2 2016 | $3,298,000 | +40.6% | 206,131 | +83.7% | 0.17% | +47.0% |
Q1 2016 | $2,346,000 | +33.4% | 112,184 | +72.2% | 0.12% | +20.6% |
Q4 2015 | $1,759,000 | -25.5% | 65,158 | -23.4% | 0.10% | 0.0% |
Q3 2015 | $2,362,000 | – | 85,011 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN | 240,000 | $1,116,000 | 99.38% |
TANG CAPITAL MANAGEMENT LLC | 9,607,934 | $44,677,000 | 8.98% |
HealthInvest Partners AB | 830,000 | $3,860,000 | 5.44% |
RTW INVESTMENTS, LP | 2,327,903 | $10,825,000 | 0.16% |
GLOBEFLEX CAPITAL L P | 185,598 | $864,000 | 0.09% |
WealthTrust Axiom LLC | 25,400 | $118,000 | 0.04% |
HOLLENCREST CAPITAL MANAGEMENT | 82,355 | $383,000 | 0.03% |
FIRST MIDWEST BANK TRUST DIVISION | 41,731 | $194,000 | 0.02% |
ACADIAN ASSET MANAGEMENT LLC | 435,387 | $2,023,000 | 0.01% |
OCCUDO QUANTITATIVE STRATEGIES LP | 17,176 | $80,000 | 0.01% |